| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.52 | 0.006 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.48 | 0.008 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.44 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.44 | 0.002 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.39 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.38 | 0.07 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.34 | 0.09 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.31 | 0.1 |